Sullivan & Cromwell Leads Global Activism Rankings in H1 2026, Defending Clients Against Elliott Investment Management, Starboard Value, and Others

Sullivan & Cromwell topped Bloomberg’s H1 2026 Global Activism league tables, successfully defending clients like Elliott Investment Management and Starboard Value in nearly 400 activism engagements over the past decade.

Read More

Sullivan & Cromwell Shortlisted for Financial Times’ Innovative Lawyers Awards for Advising Sportradar and Merck KGaA

Sullivan & Cromwell has been shortlisted for two Financial Times awards, recognizing its advisory roles in Sportradar’s CMA merger clearance and Merck KGaA’s $3.9 billion acquisition of SpringWorks Therapeutics.

Read More

Akin Advises Coller Capital as Sole Lead Investor on £500 Million Pharmacy2U Continuation Fund Managed by G Square Healthcare Private Equity LLP

Akin advised Coller Capital on a £500 million continuation fund for Pharmacy2U, marking a significant GP-led secondary transaction in European health-tech, with G Square and existing shareholders also reinvesting.

Read More

Hogan Lovells Cadwalader Advises Blue Owl Capital and Moor Park Capital Partners on £1.3 Billion Acquisition of Spire Healthcare Hospital Portfolio

Hogan Lovells Cadwalader advised Blue Owl Capital and Moor Park Capital Partners on acquiring a £1.3 billion portfolio of 12 Spire Healthcare hospitals in the UK, highlighting the appeal of UK healthcare real estate to international investors.

Read More